Please assess the completion status of the following clinical trial:

Trial Title: Effect of Intermittent Oro-esophageal Tube vs Nasogastric Tube in Tracheostomized Patients With Intracerebral Hemorrhage

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* meeting the diagnostic criteria for Intracerebral Hemorrhage.~* with placement of a tracheotomy tube.~* requiring enteral nutrition support.~* age over 18 years.~* able to cooperate with treatment and questionnaire investigation, (Generally with a Mini-Mental State Examination (MMSE) score ≥ 24) .~Exclusion Criteria:~* combined with tumors in the head, neck, esophagus, or gastrointestinal tract~* an abnormal structure observed in the oral, pharyngeal, nasal regions or esophagus~* with unstable vital signs or severe dysfunction of organs including heart, liver, lungs, or kidneys~* with severe hemorrhagic disease or bleeding tendency; 5) with contraindications for enteral nutrition~* with dysphagia caused by non-stroke-related reasons in the past

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- The observation group (Type: EXPERIMENTAL): The patients were provided with 1) basic treatment including intracranial pressure reduction, anti-infection therapy, blood pressure and blood glucose control, and 2) comprehensive rehabilitation therapy including respiratory tract management, care for tracheotomy tube, comprehensive training for hemiplegic limbs, swallowing function training, pulmonary function training, and acupuncture.~For the observation group, the nasogastric tube was removed, and Intermittent oro-esophageal tube feeding was initiated for nutrition support within 4 hours after completing the admission assessment, following the standard Intermittent oro-esophageal tube feeding procedure.
- The control group (Type: ACTIVE_COMPARATOR): The patients were provided with 1) basic treatment including intracranial pressure reduction, anti-infection therapy, blood pressure and blood glucose control, and 2) comprehensive rehabilitation therapy including respiratory tract management, care for tracheotomy tube, comprehensive training for hemiplegic limbs, swallowing function training, pulmonary function training, and acupuncture.~Patients in the control group were provided with nutrition support by the indwelling nasogastric tube. The entire feeding process strictly followed the standardized procedure for nasogastric feeding.

Based on this trial design, predict the completion outcome and termination type (if applicable).